Q1 2017 13F Holders as of 3/31/2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
80.8M
-
Number of holders
-
528
-
Total shares
-
78.7M
-
Shares change
-
+8.35M
-
Total reported value, excl. options
-
$12.2B
-
Value change
-
+$1.32B
-
Put/Call ratio
-
1.61
-
Number of buys
-
229
-
Number of sells
-
-264
-
Price
-
$154.61
Significant Holders of IDEXX LABORATORIES INC /DE - Common Stock (IDXX) as of Q1 2017
535 filings reported holding IDXX - IDEXX LABORATORIES INC /DE - Common Stock as of Q1 2017.
IDEXX LABORATORIES INC /DE - Common Stock (IDXX) has 528 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 78.7M shares
of 80.8M outstanding shares and own 97.32% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (8.91M shares), BlackRock Inc. (6.43M shares), BAMCO INC /NY/ (5.07M shares), Fundsmith LLP (4.48M shares), PRICE T ROWE ASSOCIATES INC /MD/ (4.03M shares), STATE STREET CORP (3.91M shares), Neuberger Berman Group LLC (1.98M shares), BLAIR WILLIAM & CO/IL (1.89M shares), ATLANTA CAPITAL MANAGEMENT CO L L C (1.51M shares), and Capital World Investors (1.05M shares).
This table shows the top 528 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.